Optimizing HIV Therapy in Resource Limited Settings | François Venter, MD, FCP, PhD

Global HIV Clinical Forum 2016

Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors | Anton Pozniak, MD, FRCP

Global HIV Clinical Forum 2016

Clinical Case Discussion 1 | Pedro Cahn, MD, PhD

Global HIV Clinical Forum 2016

Resistance Characteristics of Integrase inhibitors | Charles Boucher, MD, PhD

Global HIV Clinical Forum 2016

Basic Science of Integrase Inhibitors | Mark Wainberg, MD

Global HIV Clinical Forum 2016

Clinical Case Presentations - Experience with Induction-Maintenance Therapy in real life settings | José Arribas, MD

European HIV Clinical Forum 2016

Induction-Maintenance ARV Therapy: Why, Who, When and How? | Pedro Cahn, MD, PhD

European HIV Clinical Forum 2016

Clinical Utility of Integrase Inhibitors during pregnancy | Saye Khoo, MD, PhD

European HIV Clinical Forum 2016

Clinical Case Presentations – How to manage drug - drug interactions - the practice | Anna Maria Geretti, MD, PhD, FRCPath

European HIV Clinical Forum 2016

How to manage drug - drug interactions - the theory | Giovanni Di Perri, MD, PhD

European HIV Clinical Forum 2016

Impact on: Pharmacology – penetration to sanctuary sites and drug-drug interactions | Courtney Fletcher, PharmD

European HIV Clinical Forum 2016

Impact on: Virology/Resistance | Daniel Kuritzkes, MD

European HIV Clinical Forum 2016

Impact on: Adherence/tolerability | Ian McGowan, MB, ChB, DPhil, MD, FRCP

European HIV Clinical Forum 2016

Russian HIV Clinical Series | Invitation Juergen Rockstroh

Russian HIV Clinical Series 2021

Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Epidemiology of Hepatitis B in Central and Eastern Europe | Adrian Streinu Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of Drug Drug Interactions | David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of End-stage Liver Disease | Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Turkey | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015